Your browser doesn't support javascript.
loading
Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study.
Pal, Sumanta K; McGregor, Bradley; Suárez, Cristina; Tsao, Che-Kai; Kelly, William; Vaishampayan, Ulka; Pagliaro, Lance; Maughan, Benjamin L; Loriot, Yohann; Castellano, Daniel; Srinivas, Sandy; McKay, Rana R; Dreicer, Robert; Hutson, Thomas; Dubey, Sarita; Werneke, Scott; Panneerselvam, Ashok; Curran, Dominic; Scheffold, Christian; Choueiri, Toni K; Agarwal, Neeraj.
Afiliação
  • Pal SK; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA.
  • McGregor B; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Suárez C; Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Tsao CK; Tisch Cancer Institute, Mount Sinai Hospital, New York, NY.
  • Kelly W; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.
  • Vaishampayan U; Karmanos Cancer Center, Wayne State University, Detroit, MI.
  • Pagliaro L; Current affiliation: Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI.
  • Maughan BL; Department of Oncology, Mayo Clinic, Rochester, MN.
  • Loriot Y; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
  • Castellano D; Department of Cancer Medicine, Gustave Roussy Institute, INSERM 981, University Paris-Saclay, Villejuif, France.
  • Srinivas S; Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain.
  • McKay RR; Division of Medical Oncology, Stanford University Medical Center, Stanford, CA.
  • Dreicer R; University of California San Diego, San Diego, CA.
  • Hutson T; University of Virginia, Charlottesville, VA.
  • Dubey S; Charles A. Sammons Cancer Center at Baylor University Medical Center, Dallas, TX.
  • Werneke S; Genentech, Inc, South San Francisco, CA.
  • Panneerselvam A; Exelixis, Inc, Alameda, CA.
  • Curran D; Exelixis, Inc, Alameda, CA.
  • Scheffold C; Exelixis, Inc, Alameda, CA.
  • Choueiri TK; Exelixis, Inc, Alameda, CA.
  • Agarwal N; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
J Clin Oncol ; 39(33): 3725-3736, 2021 11 20.
Article em En | MEDLINE | ID: mdl-34491815
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Renais Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Renais Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article